Skip to Primary Navigation

UK MHRA outlines future of healthcare regulation with 2030 strategy

Intuitive Surgical's surgeon console during the Wave - Italian Tech Week 2026 at OGR Torino on October 7, 2026 in Turin, Italy
Photo: Stefano Guidi/Getty Images

The focus is on innovation and patient-centered care for safer products.

Laying out the plans for regulating medicines and medical devices in the coming years, the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) published its Strategy 2030 this week, entitled Health and Prosperity for All Through Scientific Excellence.

The strategy includes several key pillars:

  • Modern regulation for a changing world

Get full access, free for a month

This is a Premium article. Start your 28-day free trial to continue reading and access all content on GRIP – no payment details required.

What’s included:

  • Every new article, plus our 5,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience